Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Novatek completes construction of LNG plant in Kashira

2/14/24 NVTK

Ozon's turnover in 2023 increased by 2.1 times

2/14/24 OZON

Lenta will develop a chain of alkomarkets

2/14/24 LENT

Samolet intends to enter the construction markets of 30-35 cities

2/14/24 SMLT

CarMoney has seen a record volume of disbursements

2/14/24 CARM

Rostelecom to IPO one of its subsidiaries

2/14/24 RTKM

Polymetal will start development of Utkinskoye deposit in 2027

2/14/24 POLY

Investors in brainbox.VC will return 50% of investments

2/13/24 OTCI

Moscow Exchange resumed trading on the stock market after two hours

2/13/24 MOEX

Trading on the stock market has been suspended for more than an hour

2/13/24 MOEX